Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 40, 2016 - Issue 6
171
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang β-Thalassemia Intermedia Patients

, , , , , , , & show all
Pages 405-410 | Received 23 May 2016, Accepted 24 Sep 2016, Published online: 31 Mar 2017

References

  • Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79:704–712.
  • Taher A, Ismaeel H, Cappellini MD. Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006;37:12–20.
  • Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, editors. Disorders of hemoglobin genetics, pathophysiology, and clinical management. 2nd ed. Cambridge, NY, USA: Cambridge University Press; 2009.
  • Menzel S, Garner C, Gut I, et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet. 2007;39:1197–1199.
  • Solovieff N, Milton JN, Hartley SW, et al. Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster. Blood. 2010;115:1815–1822.
  • Bauer DE, Kamran SC, Lessard S, et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science. 2013;342:253–257.
  • Thein SL, Menzel S, Peng X, et al. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci USA. 2007;104:11346–11351.
  • Wonkam A, Ngo Bitoungui VJ, Vorster AA, et al. Association of variants at BCL11A and HBS1L-MYB with Hemoglobin F and hospitalization rates among sickle cell patients in Cameroon. PLoS One. 2014;9:e92506. doi: 10.1371/journal.pone.0092506.
  • Gibney GT, Panhuysen CI, So JC, et al. Variation and heritability of Hb F and F-cells among beta-thalassemia heterozygotes in Hong Kong. Am J Hematol. 2008;83:458–464.
  • Galarneau G, Palmer CD, Sankaran VG, et al. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet. 2010;42:1049–1051.
  • Lettre G, Sankaran VG, Bezerra MA, et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci USA. 2008;105:11869–11874.
  • Zheng CG, Liu M, Du J, et al. Molecular spectrum of α- and β-globin gene mutations detected in the population of Guangxi Zhuang Autonomous Region, People’s Republic of China. Hemoglobin. 2011;35:28–39.
  • Liu D, Zhang X, Yu L, et al. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia. Blood. 2014;124:803–811.
  • Chen W, Zhang X, Shang X, et al. The molecular basis of β-thalassemia intermedia in southern China: genotypic heterogeneity and phenotypic diversity. BMC Med Genet. 2010;11:31. doi: 10.1185/1471-2350-11-31.
  • Ho PJ, Hall GW, Luo LY, et al. Beta-thalassaemia intermedia: is it possible consistently to predict phenotype from genotype? Br J Haematol. 1998;100:70–78.
  • He S, L DM, Lai YL, et al. Prenatal diagnosis of β-thalassemia in Guangxi Zhuang Autonomous Region, China. Arch Gynecol Obstet. 2014;289:61–65.
  • Sherva R, Sripichai O, Abel K, et al. Genetic modifiers of Hb E/beta0 thalassemia identified by a two-stage genome-wide association study. BMC Med Genet. 2010;11:51. doi: 10.1185/1471-2350-11-51.
  • Nuinoon M, Makarasara W, Mushiroda T, et al. A genome-wide association identified the common genetic variants influence disease severity in β°-thalassemia/hemoglobin E. Hum Genet. 2010;127:303–314.
  • Sankaran VG, Menne TF, Xu J, et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science. 2008;322:1839–1842.
  • Chan CM, Fulton J, Montiel-Duarte C, et al. A signature motif mediating selective interactions of BCL11A with the NR2E/F subfamily of orphan nuclear receptors. Nucleic Acids Res. 2013;41:9663–9679.
  • Soza-Ried C, Hess I, Netuschil N, et al. Essential role of c-myb in definitive hematopoiesis is evolutionarily conserved. Proc Natl Acad Sci USA. 2010;107:17304–17308.
  • Suzuki M, Yamazaki H, Mukai HY, et al. Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model. Mol Cell Biol. 2013;33:1687–1695.
  • Bae HT, Baldwin CT, Sebastiani P, et al. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood. 2012;120:1961–1962.
  • He Y, Lin W, Luo J. Influences of genetic variation on fetal hemoglobin. Pediatr Hematol Oncol. 2011;28:708–717.
  • Danjou F, Anni F, Perseu L, et al. Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion. Haematologica. 2012;97:989–993.
  • So CC, Song YQ, Tsang ST, et al. The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of β-thalassaemia. J Med Genet. 2008;45:745–751.
  • Pule GD, Ngo Bitoungui VJ, Chetcha Chemegni B, et al. Association between variants at BCL11A erythroid-specific enhancer and fetal hemoglobin levels among sickle cell disease patients in cameroon: implications for future therapeutic interventions. Omics. 2015;19:627–631.
  • Sebastiani P, Farrell JJ, Alsultan A, et al. BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia. Blood Cells Mol Dis. 2015;54:224–230.
  • Sedgewick AE, Timofeev N, Sebastiani P, et al. BCL11A is a major HbF quantitative trait locus in three different populations with beta-hemoglobinopathies. Blood Cells Mol Dis. 2008;41:255–258.
  • Akinsheye I, Sol ovieff N, Ngo D, et al. Fetal hemoglobin in sickle cell anemia: molecular characterization of the unusually high fetal hemoglobin phenotype in African Americans. Am J Hematol. 2012;87:217–219.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.